This activity is hosted on the site of our educational partner

You will be connecting to our educational partner, which controls its own content, practices, and other policies.

You will be connecting to our educational partner, which controls its own content, practices, and other policies.

  • Overview
  • Pre-Assessment
  • Activity
  • Post-Test
  • Evaluation
  • Claim Credit
The Role of Advance Practice Providers in Managing Influenza — Treating Influenza

The Role of Advance Practice Providers in Managing Influenza — Treating Influenza

Format

Expert Perspective

Time to Complete

15 minutes

Released

December 31, 2019

Expires

December 30, 2020
Add to Queue


Maximum Credits

0.25 / AMA PRA Category 1 CreditTM
0.25 / AAPA Category 1 CME Credit
0.25 / AANP Contact Hour

Accredited Provider


This continuing medical education activity is provided by Vindico Medical Education.

Commercial Supporter

This activity is supported by an educational grant from Genentech, Inc.

Program Description

Although the impact of influenza varies, it places a substantial burden each year on the health of people in the United States. Many patients with influenza are not promptly diagnosed, preventing optimal delivery of treatment at early stages of the disease. Three classes of antiviral drugs are currently available for the prevention and treatment of influenza: neuraminidase inhibitors, adamantanes, and the polymerase inhibitor, baloxavir marboxil. Improved diagnostic modalities and utilization of antiviral therapy are needed to shorten the duration of illness and control disease spread. Clinicians who evaluate patients in primary care must keep apprised of new information regarding the diagnosis and treatment of influenza so they can incorporate this information into practice, reducing patient morbidity and mortality. In this educational video, expert faculty evaluate antiviral therapy options for prophylaxis and treatment of influenza as well as discuss optimal approaches to reduce illness duration and prevent complications.

Intended Audience

The intended audience for the activity is family practice physicians, nurse practitioners, physician assistants, and other health care professionals involved in the management of patients with influenza.

Educational Objectives

Upon successful completion of this activity, participants should be better able to incorporate antiviral therapies into practice for prophylaxis, prevention, and treatment of influenza, to reduce the duration

Conflicts of Interest Disclosure Policy

In accordance with the Accreditation Council for Continuing Medical Education’s Standards for Commercial Support, all CME providers are required to disclose to the activity audience the relevant financial relationships of the planners, teachers, and authors involved in the development of CME content. An individual has a relevant financial relationship if he or she has a financial relationship in any amount occurring in the last 12 months with a commercial interest whose products or services are discussed in the CME activity content over which the individual has control.

The authors disclose that they do have significant financial interests in any products or class of products discussed directly or indirectly in this activity, including research support.

Faculty

John J. Russell, MD
Clinical Professor of Family and Community Medicine
Thomas Jefferson University
Sidney Kimmel School of Medicine
Philadelphia, PA
Chair, Department of Family Medicine
Program Director, Family Medicine Residency
Abington – Jefferson Health
Abington, PA

Dr. Russell discloses the following:
Consulting Fee: GlaxoSmithKline, Sanofi Pasteur
Speakers Bureau: Sanofi Pasteur

Planning Committee

Laura Gunder McClary, DHSc, MHE, PA-C
Professor, Rocky Mountain University
Doctor of Medical Science Program
Provo, UT

Dr. Gunder McClary has no relevant financial relationships to disclose.

Ingrid Pichardo Murray, EdD, DPT, PA-C
Academic Director/Associate Professor
Physician Assistant Program
Advent Health University
Orlando, FL

Dr. Murray has no relevant financial relationships to disclose.

Reviewers

Ronald A. Codario, MD, EMBA, FACP, FNLA, RPVI, CHCP, has no relevant financial relationships to disclose.

Linda A. Giarraputo, PA-C, has no relevant financial relationships to disclose.

Accredited Provider Disclosure

Vindico Medical Education staff have no relevant financial relationships to disclose.

Signed disclosures are on file at Vindico Medical Education, Office of Medical Affairs and Compliance.

Credit

0.25

Type

AMA PRA Category 1 Credit(s)TM

Accreditation Statement

Vindico Medical Education is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Designation Statement

Vindico Medical Education designates this enduring material for a maximum of 0.25 AMA PRA Category 1 Credit(s)TM .  Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Credit

0.25

Type

AAPA Category I CME credit

Accreditation Statement


This activity was planned in accordance with AAPA CME Standards for Enduring Material Programs and for Commercial Support of Enduring Material Programs.

Designation Statement

This activity has been reviewed by the AAPA Review Panel and is compliant with AAPA CME Criteria. This activity is designated for 0.75 (0.25 per video) AAPA Category 1 CME credits. Approval is valid for one year from 12/31/2019. PAs should only claim credit commensurate with the extent of their participation.

Successful completion of the post-test is required to earn AAPA Category 1 CME credit. Successful completion is defined as a cumulative score of at least 100 percent correct.

Credit

0.25

Type

CE for Nurse Practitioners

Accreditation Statement

This activity was planned in accordance with AANP Accreditation Standards and Policies.

Designation Statement

This activity is approved for 0.25 contact hour(s) of continuing education (which includes 0.25 hours of pharmacology) by the American Association of Nurse Practitioners. Activity ID 19103990. This activity was planned in accordance with AANP Accreditation Standards and Policies.

Disclosure of Unlabeled Use

The audience is advised that this continuing medical education activity may contain references to unlabeled uses of US Food and Drug Administration (FDA)-approved products or to products not approved by the FDA for use in the United States. The faculty members have been made aware of their obligation to disclose such usage. All activity participants will be informed if any speakers/authors intend to discuss either non–FDA-approved or investigational use of products/devices.

Instructions

To participate in this CME activity, you must read the objective, answer the pretest question, view the content, and complete the posttest and evaluation. Provide only one (1) correct answer for the question. A satisfactory score is defined as answering the posttest question correctly. Upon receipt of the completed materials, if a satisfactory score on the posttest is achieved, Vindico Medical Education will issue an AMA PRA Category 1 CreditTM  Certificate,  AANP Contact Hours Certificate, or an AAPA Category 1 CME Certificate.

If you have CME Questions, please contact Vindico Medical Education at cme@vindicoCME.com.

Privacy Policy

Copyright

Created and published by Vindico Medical Education, 6900 Grove Road, Building 100, Thorofare, NJ 08086-9447. Telephone: 856-994-9400; Fax: 856-384-6680. Printed in the USA. Copyright © 2019 Vindico Medical Education. All rights reserved. No part of this publication may be reproduced without written permission from the publisher. The material presented at or in any of Vindico Medical Education continuing medical education activities does not necessarily reflect the views and opinions of Vindico Medical Education. Neither Vindico Medical Education nor the faculty endorse or recommend any techniques, commercial products, or manufacturers. The faculty/authors may discuss the use of materials and/or products that have not yet been approved by the US Food and Drug Administration. All readers and continuing education participants should verify all information before treating patients or utilizing any product.

SYSTEM REQUIREMENTS

Hardware and Software Requirements
  • A computer with an internet connection
  • Internet Browser: Internet Explorer 7.x or higher, Firefox 4.x or higher, Safari 2.x or higher, or any other W3C standards compliant browser
  • Additional Software: Adobe Flash Player and/or an HTML 5 capable browser maybe required for video or audio playback. PowerPoint or Adobe Acrobat Reader may occasionally be required
Add to Queue